SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-325885
Filing Date
2017-10-31
Accepted
2017-10-31 07:41:32
Documents
4
Period of Report
2017-10-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d470529d8k.htm 8-K 16206
2 EX-99.1 d470529dex991.htm EX-99.1 50870
3 GRAPHIC g470529g61c47.jpg GRAPHIC 26249
4 GRAPHIC g470529g81o01.jpg GRAPHIC 4858
  Complete submission text file 0001193125-17-325885.txt   109238
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37766 | Film No.: 171164043
SIC: 2835 In Vitro & In Vivo Diagnostic Substances